Research spanning multiple decades showed cannabis as potential cancer medicine.

“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems.” ~ Cancer and Metastasis Review, Oct. 2011

THC and CBD may slow down or even stop the growth of cancer cells in brain, lung, breast, liver and skin.

A link between brain cancer (glioblastoma) and cannabinoid receptors has been known since 2001.

Growth of malignant melanoma cells have been linked to anandamide since 2013.

A connection between Hodgkin’s Lymphoma and cannabinoid receptors was discovered in 2013.

Cannabis-like compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.” ~British Journal of Pharmacology, 2011

Breast cancer cells were found to contain cannabinoid receptors in 2006.

In stage IV colorectal cancer, the level of cannabinoid receptors was found to be a factor in a bad prognosis following surgery.

In pancreatic tumors, higher volumes of cannabinoid receptors were shown in patients with shorter survival time (median 6 months)

.Ovarian and prostate tumours have been found high in cannabinoid receptors.

Cannabis-like compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.” ~British Journal of Pharmacology, 2011

Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to CannabisFindings.com with appropriate and specific direction to the original content.